Trademark Search in Canada

AEGLEA

View On IC.GC.CA

CANCELLED

Last Applicant/ Owned by

Aeglea BioTherapeutics, Inc.

805 Las Cimas Parkway, Suite 100Austin TX 78746

Serial Number

2126701 filed on 8^th Jun 2021

Registration Number

TMA1227873 registered on 4^th Apr 2024

Registration expiry Date

8^th Jun 2031

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

K1P1C3

AEGLEA

Trademark usage description

pharmaceutical preparations for the treatment of genetic diseases; pharmaceutical preparations for the treatment of arginase 1 deficiency; pharmaceuti Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of genetic diseases; pharmaceutical preparations for the treatment of arginase 1 deficiency; pharmaceutical preparations for the treatment of cancer; biopharmaceutical preparations for the treatment of genetic diseases; biopharmaceutical preparations for the treatment of arginase 1 deficiency; biopharmaceutical preparations for the treatment of cancer; biotherapeutic preparations for the treatment of genetic diseases; biotherapeutic preparations for the treatment of arginase 1 deficiency; biotherapeutic preparations for the treatment of cancer; biotherapeutic preparations and substances for the treatment of genetic diseases; biotherapeutic preparations and substances for the treatment of arginase 1 deficiency; biotherapeutic preparations and substances for the treatment of cancer; enzyme replacement therapy preparations for medical purposes for the treatment of genetic diseases, arginase 1 deficiency, cancer, immunological diseases, homocystinuria, and infectious diseases; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, sepsis and infections in and of the blood, urinary tract infections, respiratory infections, eye infections, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, and immunological diseases, namely, autoimmune diseases and immunologic deficiency syndromes; biopharmaceutical preparations for the prevention and treatment of infectious diseases, namely, sepsis and infections in and of the blood, urinary tract infections, respiratory infections, eye infections, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, and immunological diseases, namely autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the treatment of homocystinuria; biopharmaceutical preparations for the treatment of homocystinuria; biotherapeutic preparations for the treatment of homocystinuria.

Classification kind code

Class [042]
Scientific research in the fields of pharmaceuticals, biopharmaceuticals, medicine, biologics, biotherapeutics, biosimilars, enzyme replacement therapeutics, and therapeutics; medical and scientific research in the field of pharmaceutical and biopharmaceutical treatment of rare genetic diseases, arginase 1 deficiency, cancer, immunological diseases, homocystinuria, and infectious diseases; providing medical and scientific research information, consultancy, and advisory services, all in the fields of pharmaceuticals, biopharmaceuticals, medicine, biologics, biotherapeutics, biosimilars, enzyme replacement therapeutics, and therapeutics treatments; design, engineering, research, development and testing services in the fields of cancer, rare genetic disease, arginase 1 deficiency treatments, immunological diseases, homocystinuria, and infectious diseases

Classification kind code

Mark Details

Serial Number

2126701

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 48 on 4^th Jan 2023	Agent Changed
Submitted for opposition 22 on 1^st Dec 2022	Search Recorded
Submitted for opposition 20 on 1^st Dec 2022	Examiner's First Report
Submitted for opposition 223 on 1^st Dec 2022	Total Provisional Refusal
Submitted for opposition 256 on 13^th Jun 2022	Notification of Possible Opposition Sent
Submitted for opposition 257 on 12^th Aug 2021	Designation Notification - Madrid Protocol
Submitted for opposition 31 on 11^th Aug 2021	Formalized
Submitted for opposition 1 on 11^th Aug 2021	Created
Submitted for opposition 228 on 8^th Jun 2021	International Registration
Submitted for opposition 30 on 8^th Jun 2021	Filed